✦ LIBER ✦

A phase II study to determine the efficacy and tolerability of intravenous ZD9331 in heavily pretreated patients with ovarian cancer

✍ Scribed by J.S Rader; D Clarke-Pearson; M Moore; L Carson; R Holloway; M.-S Kao; I Wiznitzer; E.C Douglass

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase II study of irofulven in women w

✍ Michael V. Seiden; Alan N. Gordon; Diane C. Bodurka; Ursula A. Matulonis; Richar 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 112 KB

Phase I study with a weekly 1 h infusion

✍ U. Klaassen; H. Wilke; D. Strumberg; W. Eberhardt; M. Korn; S. Seeber 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 277 KB

A phase II, randomized, multicenter stud

✍ Christos Chouaid; Faith Nathan; Kristine Pemberton; Thomas Morris 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 244 KB

A phase II study of weekly topotecan and

✍ Divya Gupta; Ricky L. Owers; Mimi Kim; Dennis Yi-Shin Kuo; Gloria S. Huang; Shoh 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 189 KB

A phase II trial to assess efficacy and

✍ Martin Schuler, Ahmad Awada, Philipp Harter, Jean Luc Canon, Kurt Possinger, Mar 📂 Article 📅 2012 🏛 Springer US 🌐 English ⚖ 303 KB

Phase II Study of Intravenous DX-8951f i

✍ C. F. VERSCHRAEGEN; C. LEVENBACK; M. VINCENT; J. WOLF; M. BEVERS; E. LOYER; A. P 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 142 KB